These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 12869020)

  • 1. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
    Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
    Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.
    Sprong T; Brandtzaeg P; Fung M; Pharo AM; Høiby EA; Michaelsen TE; Aase A; van der Meer JW; van Deuren M; Mollnes TE
    Blood; 2003 Nov; 102(10):3702-10. PubMed ID: 12881318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.
    Thomas TC; Rollins SA; Rother RP; Giannoni MA; Hartman SL; Elliott EA; Nye SH; Matis LA; Squinto SP; Evans MJ
    Mol Immunol; 1996 Dec; 33(17-18):1389-401. PubMed ID: 9171898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
    Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
    J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species.
    Zelek WM; Morgan BP
    Front Immunol; 2020; 11():612402. PubMed ID: 33424866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the C5-C5a receptor axis.
    Woodruff TM; Nandakumar KS; Tedesco F
    Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S
    Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.
    Larrick JW; Wang J; Fendly BM; Chenoweth DE; Kunkel SL; Deinhart T
    Infect Immun; 1987 Aug; 55(8):1867-72. PubMed ID: 2440808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.
    Evans MJ; Rollins SA; Wolff DW; Rother RP; Norin AJ; Therrien DM; Grijalva GA; Mueller JP; Nye SH; Squinto SP
    Mol Immunol; 1995 Nov; 32(16):1183-95. PubMed ID: 8559143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
    J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.
    Harboe M; Ulvund G; Vien L; Fung M; Mollnes TE
    Clin Exp Immunol; 2004 Dec; 138(3):439-46. PubMed ID: 15544620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of C5a in complement-activated serum does not require C6.
    Biesecker G; Wagner JL; Hugli TE
    J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of complement molecular complex C5b-9 (C5b-9) in response to poly-traumatic hemorrhagic shock and evaluation of C5 cleavage inhibitors in non-human primates.
    Paredes RM; Reyna S; Vernon P; Tadaki DK; Dallelucca JJ; Sheppard F
    Int Immunopharmacol; 2018 Jan; 54():221-225. PubMed ID: 29156357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.